Risk Paradigm Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $195K | Buy |
2,717
+451
| +20% | +$32.4K | 0.47% | 44 |
|
|
2018
Q3 | $217K | Buy |
2,266
+597
| +36% | +$57.2K | 0.43% | 45 |
|
|
2018
Q2 | $159K | Hold |
1,669
| – | – | 0.31% | 47 |
|
|
2018
Q1 | $146K | Buy |
1,669
+1,028
| +160% | +$90.2K | 0.19% | 96 |
|
|
2017
Q4 | $54.4K | Buy |
641
+403
| +169% | +$34.2K | 0.06% | 155 |
|
|
2017
Q3 | $20.6K | Buy |
+238
| New | +$20.6K | 0.03% | 192 |
|